onkuretherapeutics.com valuation and analysis
Robots.txt Information
| Robot | Path | Permission |
| GoogleBot | / | ✔ |
| BingBot | / | ✔ |
| BaiduSpider | / | ✔ |
| YandexBot | / | ✔ |
User-agent: * Disallow: /wp-admin/ Disallow: /wp-includes/ Disallow: /wp-content/plugins/ Disallow: /wp-admin/ Disallow: /wp-includes/ Disallow: /readme.html Disallow: /refer/ Disallow: /trackback/ Disallow: /xmlrpc.php Disallow: /feed/ Allow: /wp-admin/admin-ajax.php Allow: /wp-content/uploads/ Allow: /wp-content/themes/*js? Allow: /wp-content/themes/*css? Allow: /wp-content/plugins/*js? Allow: /wp-content/plugins/*css? User-agent: Mediapartners-Google* Allow: / User-agent: Googlebot-Image Disallow: /wp-content/uploads/ User-agent: Adsbot-Google Allow: / User-agent: Googlebot-Mobile Allow: / Sitemap: https://onkuretherapeutics.com/page-sitemap.xml User-agent: * Disallow: /wp-content/uploads/wpo-plugins-tables-list.json # START YOAST BLOCK # --------------------------- User-agent: * Disallow: Sitemap: https://onkuretherapeutics.com/sitemap_index.xml # --------------------------- # END YOAST | ||
Meta Tags
| Title | OnKure |
| Description | Writing the Next Chapter in Precision Medicines for Patients With OnKure Therapeutics - Writing the Next Chapter in Precision Medicines for Patients With |
| Keywords | N/A |
Server Information
| WebSite | |
| Host IP | 192.124.249.110 |
| Location | - |
Related Websites
| Site | Rank |
More to Explore
onkuretherapeutics.com Valuation
|
US$6,016,814
Last updated: 2023-05-10 21:21:27
onkuretherapeutics.com has Semrush global rank of 1,759,121. onkuretherapeutics.com has an estimated worth of US$ 6,016,814, based on its estimated Ads revenue. onkuretherapeutics.com receives approximately 694,248 unique visitors each day. Its web server is located in -, with IP address 192.124.249.110. According to SiteAdvisor, onkuretherapeutics.com is safe to visit. |
Traffic & Worth Estimates
| Purchase/Sale Value | US$6,016,814 |
| Daily Ads Revenue | US$5,554 |
| Monthly Ads Revenue | US$166,620 |
| Yearly Ads Revenue | US$1,999,434 |
| Daily Unique Visitors | 46,284 |
| Note: All traffic and earnings values are estimates. | |
DNS Records
| Host | Type | TTL | Data |
| onkuretherapeutics.com. | A | 600 | IP: 192.124.249.110 |
| onkuretherapeutics.com. | NS | 3600 | NS Record: ns69.domaincontrol.com. |
| onkuretherapeutics.com. | NS | 3600 | NS Record: ns70.domaincontrol.com. |
| onkuretherapeutics.com. | MX | 3600 | MX Record: 0 onkuretherapeutics-com.mail.protection.outlook.com. |
| onkuretherapeutics.com. | TXT | 3600 | TXT Record: MS=ms23543719 |
| onkuretherapeutics.com. | TXT | 3600 | TXT Record: google-site-verification=XizLusQqpgzFhWdiR9ZkCLpHKWx_9EqK-gc-s7DLDO4 |
| onkuretherapeutics.com. | TXT | 3600 | TXT Record: v=spf1 include:spf.protection.outlook.com -all |
| onkuretherapeutics.com. | TXT | 3600 | TXT Record: MS=ms50972445 |
HtmlToTextCheckTime:2023-05-10 21:21:27
| Skip Navigation Contact Us Search: Search Toggle Visit us on Twitter Visit us on LinkedIn Toggle Navigation Search: Search Submit About Us Our Company Our Team Management Board of Directors Scientific Advisors Investors Collaborators Our Expertise Pipeline Our Pipeline OKI-179 Our Targets News & Publications Press Releases Publications Careers Join Our Team Job Opportunities Contact Us Writing the Next Chapter in Precision Medicines for Patients With Cancer Scroll Down Writing the Next Chapter in Precision Medicines for Patients With Cancer Discovering and developing the next generation of oncology precision medicines through: Industry leaders with a proven track record of success Building a broad pipeline of potentially best-in-class tumor-agnostic therapies Potentially differentiated HDAC inhibitor entering Phase 2 in multiple cancer types News December 6, 2022 OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations June 21, 2022 OnKure |
HTTP Headers
HTTP/1.1 301 Moved Permanently Server: Sucuri/Cloudproxy Date: Wed, 03 Nov 2021 12:00:21 GMT Content-Type: text/html Content-Length: 162 Connection: keep-alive X-Sucuri-ID: 20010 Location: https://onkuretherapeutics.com/ HTTP/2 406 server: nginx date: Wed, 03 Nov 2021 12:00:22 GMT content-type: text/html; charset=UTF-8 x-sucuri-id: 20010 x-xss-protection: 1; mode=block x-frame-options: SAMEORIGIN x-content-type-options: nosniff content-security-policy: upgrade-insecure-requests; cache-control: no-cache wpo-cache-status: cached last-modified: Tue, 02 Nov 2021 18:52:07 GMT x-sucuri-cache: EXPIRED |
onkuretherapeutics.com Whois Information
Domain Name: ONKURETHERAPEUTICS.COM Registry Domain ID: 1649583343_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2021-10-01T13:13:41Z Creation Date: 2011-04-06T22:08:12Z Registry Expiry Date: 2022-04-06T22:08:12Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS69.DOMAINCONTROL.COM Name Server: NS70.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2021-10-05T12:05:12Z <<< |